do not combine dpp-4 inhibitors with glp-1 receptor agonists guidance Why are DPP-4 ( Dipeptidyl peptidase 4 inhibitors in

Early enthusiasm was tempered due to concerns related to cost, tolerability, long-term adherence, and pharmacoequity, as well as open questions related to the long-term safety profile

Bacteria have even more time to ferment sulfur-containing compounds

Another phase II study assessed the safety and efficacy of varying doses of retatrutide, included participants with a BMI of 25 to 50 kg/m 2 and an HbA1c of 7.0% to 10.5% [114]

doi: 10.1016/j.regpep.2004.06.025

Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity

In addition to having a higher cancer incidence, patients with T2D have been shown to have poorer cancer prognosis than patients without T2D (4244)